Biomeme is a biotechnology company located in Philadelphia, Pennsylvania, specializing in innovative molecular diagnostics and genetic analysis. Situated at 401 N Broad St Suite 222, the company focuses on developing portable and accessible technologies designed to streamline biological testing processes. Its work centers on providing tools that enhance the ability to detect and analyze pathogens and genetic material in a variety of settings, from clinical laboratories to field environments.

The company’s approach integrates advanced biotechnology with practical applications, making complex genetic testing more efficient and user-friendly. By leveraging cutting-edge scientific techniques, Biomeme supports research, public health, and clinical decision-making with reliable data. Their products often emphasize portability and ease of use, addressing the need for rapid, accurate testing outside traditional laboratory settings.

Biomeme serves a diverse clientele, including healthcare providers, researchers, and organizations involved in infectious disease monitoring and environmental testing. The company’s technology contributes to faster diagnosis and better management of health conditions by enabling point-of-care and on-site testing capabilities. This flexibility allows for real-time data collection and analysis, which can be crucial in outbreak situations or remote locations.

Located in the heart of Philadelphia, Biomeme operates within a vibrant biotechnology ecosystem, fostering collaboration and innovation. The company continues to explore new applications of molecular diagnostics, aiming to improve accessibility and accuracy in genetic testing. For inquiries or more information about their offerings, Biomeme can be reached at 267-930-7707.